Left side grafting is procedure of choice for adult-to-adult living donor liver transplantation

October 29, 2009,

A recent study by doctors at Shinshu University, School of Medicine, in Japan determined that left side grafting has lower risk to donors compared to grafts taken from the right lobe, and it appears to be the procedure of choice for adult-to-adult living donor liver transplantation (LDLT). Researchers also found that graft size was not the only cause behind "small-for-size graft syndrome," a severe complication resulting in organ malfunction and transplant failure. These findings appear in the November issue of Liver Transplantation, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases.

In the current study, Toshihiko Ikegami, M.D. and colleagues report on the outcomes of the 120 adult LDLTs they performed through October 2007. Patients were divided into two groups: group S consisted of 33 patients who received grafts < 35% of their standard liver volume (slv), and group l consisted of 87 patients who received liver grafts ≥ 35% of their slv.

Results show the 1- and 5-year survival rates in group S were 80.7% and 64.2% respectively; and in group L 90.8% and 84.9%, with no significant difference between groups. Between 1 and 5 years after LDLT, 7 patients died with causes of death including cerebral infarction, recurrence of liver cancer, uterine cancer, and sepsis. "These deaths occurred in patients with good liver function who had resumed their normal lives," commented Dr. Ikegami. "The causes of death were not related to insufficient graft size."

Past studies have recommended a graft volume to recipient standard liver volume (GV/SLV) ratio of >40% and a graft-to-recipient weight ratio (GRWR) of ≥ 0.8% to achieve good graft and recipient survival rates. In the current study patients in group S had a good survival rate, despite a GV/SLV ratio below 35% and a GRWR not exceeding 0.8%. Dr. Ikegami points out, "Our research shows small graft size does not appear to be the only cause of small-for-size graft syndrome. The prognosis of recipients with liver grafts < 35% of their slv is comparable to that of recipients with larger grafts."

According to the U.S. Department of Health and Human Services, 3,549 deceased donor and 249 LDLTs (5%) were performed in 2008. In Japan, 99% of all liver transplantations use living donors. The authors speculate that the lower percentage of LDLTs in the U.S. could be attributed to a highly publicized donor death in 2002 and that it is conceivable that the next donor death in Japan could lead to a similar resistance in that country. "We feel that left side grafts should be used more frequently in adult-to-adult LDLT, considering the lower risk to donors compared to right lobe grafts," recommended Dr. Ikegami.

Currently, the United Network for Organ Sharing (UNOS), an organization that facilitates all organ transplants in the U.S., indicates there are close to 16,000 patients on the waiting list to receive a liver. "As the world faces an incredible growth of patients requiring life-saving liver transplantation to treat their end stage liver disease, the need for LDLT will continue due to a lack of adequate alternative sources," said David Mulligan, M.D., from the Mayo Clinic Hospital in his editorial also published in the November issue of Liver Transplantation. "I believe we (liver transplant surgeons) should share techniques and learn new strategies as Dr. Ikegami's team reported, employing them in a balanced practice to achieve optimal results for recipients and donors so that both right and left liver grafts may be effectively transplanted in the appropriate clinical situations," added Dr. Mulligan.

More information:

Article: "Prognosis of Adult Patients Transplanted with Liver Grafts <35% of Their Standard Liver Volume," Toshihiko Ikegami, Yuichi Masuda, Yasunari Ohno, Atsuyoshi Mita, Akira Kobayashi, Koichi Urata, Yuichi Nakazawa, Shirou Miwa, Yasuhiko Hashikura, Shinichi Miyagawa. Liver Transplantation; Published Online: October 29, 2009 (DOI: 10.1002/lt.21716); Print Issue Date: November 2009.

Editorial: "Living Donor and Donor Graft Size: How small can we go to reduce risk to the donor and at what cost to the recipient?" David MullDOI: 10.1002/lt.21922tation; Published Online: October 29, 2009 (DOI: 10.1002/lt.21922); Print Issue Date: November 2009

Source: Wiley (news : web)

Related Stories

Recommended for you

Building better tiny kidneys to test drugs and help people avoid dialysis

February 16, 2018
A free online kidney atlas built by USC researchers empowers stem cell scientists everywhere to generate more human-like tiny kidneys for testing new drugs and creating renal replacement therapies.

Expanding Hepatitis C testing to all adults is cost-effective and improves outcomes

February 16, 2018
According to a new study, screening all adults for hepatitis C (HCV) is a cost-effective way to improve clinical outcomes of HCV and identify more infected people compared to current recommendations. Using a simulation model, ...

Study suggests expanded range for emerging tick-borne disease

February 16, 2018
Human cases of Borrelia miyamotoi, a tick-borne infection with some similarities to Lyme disease, were discovered in the eastern United States less than a decade ago. Now new research led by the Yale School of Public Health ...

Flu shot only 36 percent effective, making bad year worse (Update)

February 15, 2018
The flu vaccine is doing a poor job protecting older Americans and others against the bug that's causing most illnesses.

IFN-mediated immunity to influenza A virus infection influenced by RIPK3 protein

February 15, 2018
Each year, influenza kills half a million people globally with the elderly and very young most often the victims. In fact, the Centers for Disease Control and Prevention reported 37 children have died in the United States ...

A new class of drug to treat herpes simplex virus-1 infection

February 14, 2018
For patients with the herpes simplex-1 virus (HSV-1), there are just a handful of drugs available to treat the painful condition that can affect the eyes, mouth and genitals.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.